Agomelatine |
Formulary
|
Tablets 25mg Major Depressive Episodes. LSCFT to approve all applications to use - patients currently on treatment can continue. |
![]() ![]() ![]() |
![]() ![]() ![]() ![]() ![]() ![]() |
Duloxetine Cymbalta® |
Formulary
|
Capsules (Cymbalta®) 30mg, 60mg Third line use within LSCFT. CAUTION: available as another brand Yentreve for stress urinary incontinence. Recommended that prescriptions state the brand name Cymbalta. |
![]() ![]() |
![]() ![]() ![]() ![]() ![]() ![]() |
Venlafaxine |
Formulary
|
Tablets 37.5mg, 75mg M/R capsules 225mg - to be prescribed as Vencarm XL in primary care Third line use only. Consider cardiovascular history e.g. uncontrolled hypertension, and risk of overdose. Higher propensity for discontinuation. |
![]() |
![]() ![]() ![]() ![]() ![]() ![]() |